When No News is Good News: How Recordati Passed a Recent Inspection with No Findings

Recordati moved from a fully outsourced to a hybrid clinical operations model, using Veeva's Clinical Operations platform to manage up to 85 studies across 38 countries. The company eliminated more than 20 manual trackers, reduced document approval cycles by 25%, and added new roles such as clinical trial liaison managers. As a result, Recordati passed a recent regulatory inspection with zero findings, improving data governance and compliance readiness ahead of the new ICH GCP E6(R3) guidelines requiring structured sponsor oversight of outsourced trials.

Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.